The E2F transcription factor is a cellular target for the RB protein. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR (1991) Cell 65: 1053-61 Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Mudryj M, Devoto SH, Hiebert SW, Hunter T, Pines J, Nevins JR (1991) Cell 65: 1243-53 ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer. Miller TW, Balko JM, Fox EM, Ghazoui Z, Dunbier A, Anderson H, Dowsett M, Jiang A, Smith RA, Maira SM, Manning HC, González-Angulo AM, Mills GB, Higham C, Chanthaphaychith S, Kuba MG, Miller WR, Shyr Y, Arteaga CL (2011) Cancer Discov 1: 338-51 E2f binding-deficient Rb1 protein suppresses prostate tumor progression in vivo. Sun H, Wang Y, Chinnam M, Zhang X, Hayward SW, Foster BA, Nikitin AY, Wills M, Goodrich DW (2011) Proc Natl Acad Sci U S A 108: 704-9 Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells. Davis JN, McCabe MT, Hayward SW, Park JM, Day ML (2005) Cancer Res 65: 3633-42 siRNA-mediated gene silencing: a global genome view. Semizarov D, Kroeger P, Fesik S (2004) Nucleic Acids Res 32: 3836-45 E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation. Nip J, Strom DK, Eischen CM, Cleveland JL, Zambetti GP, Hiebert SW (2001) Oncogene 20: 910-20 Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Roussel MF, Davis JN, Cleveland JL, Ghysdael J, Hiebert SW (1994) Oncogene 9: 405-15 Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1. Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL (2001) Oncogene 20: 6983-93 An E2F dominant negative mutant blocks E1A induced cell cycle progression. Dobrowolski SF, Stacey DW, Harter ML, Stine JT, Hiebert SW (1994) Oncogene 9: 2605-12 E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Hiebert SW, Packham G, Strom DK, Haffner R, Oren M, Zambetti G, Cleveland JL (1995) Mol Cell Biol 15: 6864-74 An E2F binding-deficient Rb1 protein partially rescues developmental defects associated with Rb1 nullizygosity. Sun H, Chang Y, Schweers B, Dyer MA, Zhang X, Hayward SW, Goodrich DW (2006) Mol Cell Biol 26: 1527-37 E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis. Nip J, Strom DK, Fee BE, Zambetti G, Cleveland JL, Hiebert SW (1997) Mol Cell Biol 17: 1049-56 Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Hiebert SW (1993) Mol Cell Biol 13: 3384-91 Oncogenes induce and activate endogenous p73 protein. Zaika A, Irwin M, Sansome C, Moll UM (2001) J Biol Chem 276: 11310-6 c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases. Alexandrow MG, Moses HL (1998) J Cell Biochem 70: 528-42 Indirect and direct disruption of transcriptional regulation in cancer: E2F and AML-1. Meyers S, Hiebert SW (1995) Crit Rev Eukaryot Gene Expr 5: 365-83 Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression. Nip J, Hiebert SW (2000) Cell Biochem Biophys 33: 199-207
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.